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Abstract
Genome analysis using next generation sequencing technologies has revolutionized the characterization of lactic
acid bacteria and complete genomes of all major groups are now available. Comparative genomics has provided
new insights into the natural and laboratory evolution of lactic acid bacteria and their environmental interactions.
Moreover, functional genomics approaches have been used to understand the response of lactic acid bacteria to
their environment. The results have been instrumental in understanding the adaptation of lactic acid bacteria in
artisanal and industrial food fermentations as well as their interactions with the human host. Collectively, this has
led to a detailed analysis of genes involved in colonization, persistence, interaction and signaling towards to the
human host and its health. Finally, massive parallel genome re-sequencing has provided new opportunities in
applied genomics, specifically in the characterization of novel non-GMO strains that have potential to be used in
the food industry. Here, we provide an overview of the state of the art of these functional genomics approaches
and their impact in understanding, applying and designing lactic acid bacteria for food and health.
Introduction & outline
Lactic acid bacteria (LAB) and humans share a long and
intricate history. Well known are the first food fermen-
tations reported in ancient times that contributed to the
preservation and quality improvement of raw plant,
meat and milk substrates. Most likely the transition
from hunter-gatherers to an agricultural lifestyle, some
10,000 years ago, contributed to the further develop-
ment of these food fermentations that are now practiced
worldwide on an industrial scale. However, our interac-
tions with LAB are more intimate and have a much
longer history than the food fermentations that were
initiated by the LAB present at that time (Figure 1). In
addition to many plants and animals, the human body is
also colonized by LAB and early culturing studies already
documented the presence of LAB at different locations, e.
g. the gastro-intestinal tract or the oral cavity [1]. How-
ever, many microbes cannot yet be cultured and this also
holds for LAB [2]. Until recently, technological
limitations precluded the global characterization of
human microbiota in terms of composition, diversity and
dynamics. Massive parallel sequencing and other high
throughput approaches have offered novel ways to
explore and examine the microbiota from different
human body cavities [3-5]. Much attention has been
given to the human gastro-intestinal (GI) tract but the
number of endogenous (autochtonous) LAB in the
human system is rather low (Douillard and De Vos, in
press; see also below). This contrasts with many animals
where the GI-tract is a well-established habitat for high
numbers of endogenous LAB, such as the fore-stomach
of mice and other rodents, as well as the crop of chicken
and other birds [6,7]. Hence, these animal systems, simi-
lar to many plants that are colonized with LAB in the
phyllosphere, may constitute reservoirs for LAB found in
food fermentations or even the human body (Figure 1).
In retrospect, it may be argued that the low level of
endogenous LAB in human explains the impact of pas-
senger (allochtonous) LAB on the human host, as exem-
plified with LAB that are marketed as probiotics and
after consumption have shown to provide health bene-
fits [8,9]. The continuing consumer interest in these and
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other LAB-containing functional foods may be a reason
for the special fondness for these bacteria that go
beyond any personal affection [10]. This interest has a
long history as the first association of LAB with tradi-
tional fermentations, naturalness and long life, has been
described over 100 years ago for what is now known as
Lactobacillus delbrueckii subsp. bulgaricus [11]. More-
over, it is widely known that LAB are highly versatile
and include phylogenetically related bacterial taxa that
are essentially non-pathogenic.
The early days of the genome sequencing era witnessed
a strong focus on pathogens, starting with Haemophilus
influenza in 1995 [12]. In hindsight, this medical focus
explains why the first LAB genomes were only deci-
phered some years later, in the early 2000s with Lactococ-
cus lactis subsp. lactis [13] and Lactobacillus plantarum
[14]. Ever since, the number of sequenced LAB genomes
has grown exponentially and currently genomic data
from over 100 LAB species and strains are available in
various public databases. These offer a wealth of informa-
tion, to further understand LAB with respect to their
gene content, their properties, and their ecological role in
human health as well as in food fermentations [15].
The present review aims at discussing and describing the
latest functional genomic advances in LAB species that
are associated with food and health (Figure 1). As proto-
type functional genomics studies rely on a complete gen-
ome sequence, we focus here on the LAB that comply
with this criterion and these include rod-shaped LAB
(Lactobacillus) and a dozen coccoid LAB, including
Lactoccoccus, Streptococcus, Enterococcus, Pediococcus
spp. and Oenococcus spp. (Table 1). Remarkably, this
morphological distinction is reflected in a dichotomy in
the genome-based phylogenetic tree (Figure 2). We will
specifically focus on food-related fermentations where
much basic progress has been on the global expression
control using transcriptome and proteome approaches
that are facilitated by the fact that these systems are easily
accessible or can be mimicked in the laboratory. In con-
trast, the human associated LAB are more difficult to
access and most studies that will be discussed relate to
LAB with clear health benefits to the human host. Finally,
we will address the evolutionary impact of the genomic
adaptations (Figure 1) and describe some of the latest
genomics approaches applied to LAB for improved food
fermentations or health benefits.
Functional genomics of LAB in food
fermentations
The use of LAB in industrial fermentations represents a
multi-billion dollar industry with the dairy products
cheese and yoghurt as the most produced commodities
[16]. Hence, considerable attention is given to the function
of LAB during the fermentation of milk into the final pro-
duct. The most important LAB used as starters in these
dairy fermentations are Lactococcus lactis, Streptococcus
thermophilus, Lactobacillus delbruekii subsp. bulgaricus,
while in some cases also some Leuconostoc or other Lacto-
bacillus spp. are used. Representative strains of these star-
ter bacteria have been genomically characterized (Table 1)
[16]. However, in many cases the genome sequences of
industrial starter strains have not been determined yet or
not been made available in public databases. This is exem-
plified by the case of the cheese starters that in most cases
belong to Lactococcus lactis subsp. cremoris. In addition to
the genomes of strain MG163 and its derivative NZ9000,
Figure 1 Overview of LAB associations with plants and animals, human and foods. The estimated time frames of the evolutionary events
relating to the emergence of human (top) and domestication (bottom) are indicated - please note their different dimensions. For a further
explanation, see text.
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Table 1 Genomic features of a selected number of lactic acid bacteria related to human lifestyle and health.
Bacterial species Example of
Sequenced Strain
Isolation Source Genome Size (Mbp) Number of
Plasmids
%GC Number of Proteins References
Lactobacilli
Lactobacillus acidophilus
Lactobacillus amylovorus
Lactobacillus brevis
Lactobacillus buchneri
Lactobacillus casei
Lactobacillus crispatus
Lactobacillus delbrueckii subsp. bulgaricus
Lactobacillus fermentum
Lactobacillus gasseri
Lactobacillus helveticus
Lactobacillus iners
Lactobacillus jensenii
Lactobacillus johnsonii
Lactobacillus kefiranofaciens subsp. kefiranofaciens
Lactobacillus paracasei subsp. casei
Lactobacillus plantarum
Lactobacillus reuteri
Lactobacillus rhamnosus
Lactobacillus ruminis
Lactobacillus salivarius subsp. salivarius
Lactobacillus sakei subsp. sakei
NCFM
GRL1112
ATCC 367
ATCC 11577
BL23
EM-LC1
ATCC 11842
IFO 3956
ATCC 33323
DPC 4571
AB-1
269-3
NCC 533
ZW3
N1115
WCFS1
DSM 20016
GG
ATCC 25644
UCC118
23K
GI tract (Feces)
Pig GI Tract (Feces)*
Unknown
Oral Cavity
Food (Cheese)
GI Tract (Feces)
Food (Dairy product)
Food (Plant)
Human origin
Food (Cheese)
Vaginal Cavity
Vaginal Cavity
GI Tract (Intestine)
Food (Kefir)
Food (Dairy products)
Oral Cavity (Saliva)
GI Tract (Intestine)
GI Tract (Intestine)
GI Tract (Intestine)
GI Tract (Intestine)
Food (Meat)
1.99
2.13
2.34
2.86
3.08
1.83
1.87
2.1
1.89
2.08
1.29
1.69
1.99
2.35
3.06
3.35
2.0
3.01
2.07
2.13
1.88
0
2
2
n.d.
0
n.d.
0
0
0
0
0
n.d.
0
2
4
3
0
0
0
3
0
34.7
38.1
46.0
39,5
46.3
37.0
49.7
51.5
35.3
37.1
32.7
34.4
34.6
37.4
46.5
44.4
38.9
46.7
43.7
33.0
41.3
1,832
2,121
2,218
3,002
2,997
1,751
1,529
1,843
1,755
1,610
1,209
1,575
1,821
2,162
2,985
3,063
1,900
2,913
2,153
2,013
1,871
[112]
[195]
[19]
DS
[196]
DS
[19]
[197]
[19]
[113]
[154]
DS
[198]
[199]
[200]
[201]
DS
[69]
[111]
[106]
[202]
Lactococci
Lactococcus lactis subsp. lactis
Lactococcus lactis subsp. cremoris
IL1403
MG1363
Food (Cheese)
Food (Dairy Products)
2.37
2.53
0
0
35.3
35.7
2,277
2.434
[13]
[203]
Streptococci
Streptococcus salivarius
Streptococcus thermophilus
CCHSS3
CNRZ1066
Oral Cavity
Food (Yoghurt)
2.22
1.8
0
0
39.9
39.1
2,027
1,914
DS
[181]
Enterococci
Enterococcus faecalis
Enterococcus faecium
V583
DO
Clinical Sample (Blood)
Clinical Sample
3.36
3.05
3
3
37.4
37.9
3,264
3,114
[204]
[205]
Oenococci
Oenococcus oeni PSU-1 Food (Plant) 1.78 0 37.9 1,691 [19]
Pediococcus
Pediococcus pentosaceus
Pediococcus claussenii
ATCC 25745
ATCC BAA-344
Food (Plant)
Food (Beer)
1.83
1.98
0
8
37.4
37.0
1,752
1,881
[19]
[182]
Leuconostoc
Leuconostoc mesenteroides
Leuconostoc citreum
Leuconostoc gelidum
Leuconostoc carnosum
Leuconostoc kimchi
Leuconostoc gasicomitatum
ATCC 8293
KM20
JB7
JB16
IMSNU 11154
LMG 18811T
Food (Olives)
Food (Kimchi)
Food (Kimchi)
Food (Kimchi)
Food (Kimchi)
Food (Spoilage)
2.08
1.9
1.89
1.77
2.1
1.95
1
4
0
4
5
0
37.7
38.9
36.7
37.1
37.9
36.7
2,003
1,820
1,796
1,691
2,129
1,912
[19]
[136]
[206]
[207]
[208]
[209]
Legend: DS, Direct Submission to sequence databases; n.d, not defined; *, No human isolates have been sequenced yet. Due to some discrepancies between the original references and the sequence databases, the
data shown in the table were exclusively retrieved from NCBI databases as on 4th of April 2014.
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widely used as a host with the NICE system [17,18], only 4
other complete genomes of this taxon have been reported.
These genomes include their plasmid complement, which
is of crucial importance as it harbors many important
dairy functions [16]. The first strain was SK11, a well-stu-
died good flavor-producing strain used as model in earlier
genetic studies [19,20]. More recent examples include
strain A76, isolated from a cheese production system and
strain UC 509.9, an Irish starter with the smallest genome
[21]. Moreover, the complete genome of Lactococcus lactis
subsp. cremoris KW2, derived from a corn-fermentation,
has been elucidated [22]. This and another plant isolate,
Figure 2 A phylogenetic tree of based on sequences of 7 housekeeping genes (recA, rpoD, dnaK, infC, rplA, rpsB and rpmA) from the
36 LAB species. The tree was generated using previously described computational methods [210-219]. Species were colored according to their
genus (purple, Leuconostoc spp. ; yellow, Lactobacillus spp. ; blue, Pediococcus spp.; green, Lactococcus spp.; pink, Streptococcus spp. ; orange,
Enterococcus spp. ; grey, Oenococcus spp. ). In addition, the presence of isolates in a particular niche are indicated by colored dots (dark green,
plant material; green, food products; orange, oral cavity; purple, gastro-intestinal tract; magenta, vaginal cavity and blue, other body sites and
clinical isolates). This illustrates the ecological versatility of each species but does not further detail its ecological role, i.e. transient
(allochthonous) or endogenous (autochthonous).
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Lactococcus lactis subsp. lactis KF147, isolated from mung
bean sprouts, with one of the largest lactococcal genomes
[23], serve as models for domestication studies (Figure 1)
and will be discussed below.
In recent years genomic interest has developed into the
so called Non-Starter LAB (NSLAB) that are naturally
present in dairy fermentations and in some cases have
been developed into adjunct starters that contribute to
flavor development or quality improvement of fermented
foods [24,25]. An example is the recent genomic charac-
terization of Lactobacillus helveticus strain CNRZ 32,
used as an adjunct starter to reduce bitterness and found
to encode 4 different cell-envelope proteinases, in con-
trast to other Lactobacilli that have one or none [26].
A variety of functional genomics approaches have
been reported in the last decade that relate to LAB
found in food fermentations. Most have focused on the
dairy LAB and here we will discuss the salient features
of the common elements that relate to the control of
gene expression and serve as models for other LABs.
Moreover, functional studies have targeted a variety of
foods where attention has been focused on starter LAB,
NSLAB and spoilage LAB. Finally, in these studies a ser-
ies of discoveries have been described that affect the
lifestyle of LAB and these are briefly summarized.
Growth & global regulation
LAB are known to be rather fastidious bacteria that
compete based on rapid growth and lactic acid produc-
tion in a selected number of habitats (see Figure 2)
Genomic-based metabolic reconstructions and modeling
have confirmed the dependence on external sources of
sugar and protein that are found in complex media such
as milk, meat and some plant materials. So much atten-
tion has been focusing on the control of carbon and
nitrogen metabolism.
By far the most important factor controlling sugar
degradation in LAB is the catabolite control protein
CcpA. The first ccpA gene of LAB was discovered in
Lactococcus lactis MG1363 and found to act as a tran-
scriptional activator of the lactic acid synthesis (las)
operon with the order pfk-pyk-ldh [27]. Using sensitive
microarray analysis in wild-type MG1363 and an iso-
genic ccpA deletion strain, the time-dependent global
regulon was uncovered and allowed the identification of
82 CcpA binding sites, known as catabolite responsive
elements (cre), predicting the role of CcpA in sugar
transport and other metabolic processes [28]. Recently,
a high-resolution crystal structure of the 76 kDa homo-
dimer has been solved and a first analysis of the interac-
tion between the cre sites and CcpA has been made for
the cellobiose operon [29,30]. New aspects on the role
of CcpA in global control are continuously being uncov-
ered by using transcriptional and proteomic studies in
many LAB [31-35]. Moreover in other cocci besides
Lactoccocus spp., CcpA is an important control system,
as demonstrated in Streptococcus thermophilus and
Enterococcus faecalis [36,37]. In an elegant metabolic
and transcriptional study it was recently found that rest-
ing cells of MG1363 at pH 5.1 showed enormous pools
of lactic acid, reaching levels of 700 mM inside the cells
[38]. Apart from various stress-response genes and the
membrane bound ATPase genes, also various glycolytic
genes belonging to the las operon were overexpressed.
Another recent study addressed the transcriptional net-
work of Lactococcus lactis MG1363 in milk and identified
CcpA as one of the major regulators in addition to others
that are discussed below. Moreover, 2 new potential
CcpA target sites were identified and are suggested to be
involved in fine tuning of the CcpA mediated control
[39]. The organization of the ccpA gene in many LAB is
such that it is juxtaposed but divergently transcribed
from the prolidase-encoding pepQ gene, indicating a link
between carbon and nitrogen metabolism, as first
observed in Lactococcus lactis MG1363 [28]. While car-
bon control is highly relevant for LAB, the tight control
of nitrogen metabolism may be even more important as
amino acid synthesis is a costly cellular process.
Several nitrogen control systems are present in LAB
and the most studied include GlnR and CodY. While
GlnR is present in all LAB genomes, CodY is only present
in Lactocccus, Streptococcus and Enterococcus spp. [40]. A
comparative genomic study of GlnR regulon, revealed its
target site to be present in all LAB genomes and, sup-
ported by published transcriptome analyses, predicted
GlnR to be involved in controlling the import of nitro-
gen-containing compounds and the synthesis of intracel-
lular ammonia under conditions of high nitrogen
availability [40]. In Lactococcus lactis MG1363 GlnR was
found to be rather specific but CodY appeared to be a
much more global control system [41]. This appeared to
be the cases for all other coccoid LAB where it is present.
Similar to the identification of the CcpA regulon, a com-
parative transcriptome approach using an isogenic codY
mutant was followed to identify the CodY regulon in
Lactococcus lactis MG1363 [42]. Over 30 genes mainly
involved in amino acid metabolism were identified to be
under control of CodY in strain MG1363 and in later
study in strain IL1403 some more were predicted based
on the CodY target (CodY box) in the genome of this
strain [43]. The CodY box is present in the promoter of
the codY gene, explaining that codY regulates its own
synthesis and does so in response to branched chain
amino acids [42]. Importantly, CodY controls the proteo-
lytic system of Lactococcus lactis and notably the
cell-wall proteinase (PrtP), the key enzyme in milk degra-
dation that prior to the genomic era was shown to be
controlled at the transcriptional level by milk-derived
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peptides [44]. During growth of strain MG1363 in milk,
CodY also acts as a regulator of a major network and
detailed transcriptional studied identified a second CodY
box in the intergenic regions of 3 operons but the func-
tion of this element remains enigmatic in absence of
further experimental work [39]. An integrated transcrip-
tomic and proteomic analysis of the adaptation of strain
IL1403 to isoleucine starvation showed that CodY was
specifically dedicated to the control of the supply of this
branched chain amino acid [45]. In Streptococcus thermo-
philus CodY was found to be also involved in the control
of the proteolytic system but the study failed to identify a
conserved CodY box, indicative of a species-specific cis-
acting control elements [46]. Remarkably, CodY in
pathogenic Streptococci was shown to provide a link
between amino acid and carbon metabolism as well
as virulence factors such as nasopharynx colonization
and the synthesis of exoproteins [47,48]. It would be of
interest to determine whether CodY of Streptococcus sali-
varius has a similar role in the colonization of this and
related species in the oral or other human related cavities
(see below). The absence of a codY gene in the genomes
of Oenococcus and Pediococcus suggests that these bac-
teria have a life style where they do not need such an
intricate protein control [40]. Alternatively, these bacter-
ial species may employ different regulatory mechanisms,
possibly involving unrecognized regulators.
Apart from the above-mentioned CcpA, GlnR and
CodY, many other specific and global regulators have
been described and functionally studied. In many cases
new links may be observed as the control systems all
seem to be interlinked. With the development of high
throughput transcriptome and RNAseq approaches, new
avenues to identify and map these are emerging. The
recent analysis of the global regulatory networks, identi-
fied during growth of Lactococcus lactis subsp. cremoris
MG1363 in milk, is such an example [39]. This is
expected to be followed by other studies that will provide
insights into the global control, the cis-acting elements,
and their nodes. The challenge is to relate these tran-
scriptional networks to the metabolic networks that are
now well-developed to increase the predictability of LAB
in the model systems, in food products and in association
with human [49].
Expression in foods
To improve the understanding of growth and function of
LAB in fermented foods, numerous global transcrip-
tional, proteomic and recently also metabolomic studies
have been performed. Model and starter strains of Lacto-
coccus lactis have been the first to be studied. A lactose-
proficient derivative of the model strain MG1363 was
used in an artificial cheese system using an expression
technology approach [50]. While a series of genes
involved in amino acid transport and metabolism were
identified, the approach suffered from the fact that
the strain used was plasmid-free and did not contain the
PrtP-encoded system and hence was not proteolytic. This
caveat also applies to the elegant study of strain MG1363
in milk elucidating the global networks [39]. However,
several other studies have addressed the expression in
cheese of starter lactococci that are capable of rapid
growth in milk. Using cheeses made from milk concen-
trated by ultrafiltration (UF-Cheese) and the starter
Lactococcus lactis subsp. lactis biovar diacetylactis LD6,
a detailed study was made of the in situ global gene
expression [51]. Genes of the proteolytic system were
increased due to down-regulation of CodY repression,
while acid and oxidative stress-related genes were
increased. Moreover, carbon limitation was apparent and
involved release of CcpA-mediated control. In similar
UF-Cheeses made with strain LD6, recently the metabo-
lites were determined using an unsupervised mass-spec-
tometry approach, illustrating the power of other non-
targeted functional approaches [52]. In an unrelated
study, four Lactococcus lactis subsp. cremoris starter
strains (SK11, and proteolytic variants of HP, Wg2 and
E8) were used in parallel cheese vats and analyzed for
their transcriptomic response [53]. This resulted in the
definition of a core transcriptome with almost 200 genes,
mainly encoding for house-keeping functions but also
those involved in cysteine metabolism. Several of these
were found to be under control of the CodY regulator,
reiterating the common theme discussed above. As indi-
cated below, correlations between CcpA, CodY and the
stringent response exist and it is expected that these reg-
ulatory circuits are all operating during these complex
fermentations in cheese making. As often mixtures of
LAB strains are used as cheese starter cultures, various
approaches have been developed to differentiate between
the components of the starter. Various metagenomics
and quantitative PCR approaches have been tested and
shown to have potential for strain differentiation or
expression [54,55]. Sequence analysis of 16S rRNA tran-
scripts has recently been used to identify the microbial
composition and activity of Cheddar cheese batches, iden-
tifying both LAB and NSLAB. These and similar investiga-
tions can be coupled to RNAseq studies to analyze the
expression in real time of the different components.
Only few other global gene expression studies have
been performed in food products other than those
derived from fermented milk. The global transcriptome
of Lactococcus garviae, a fish and opportunistic human
pathogen was analyzed and revealed a heme-dependent
and cold-induced respiration system [56]. This had
already been described some years ago in another strain
of Lactococcus garviae [57]. Such a respiration system
was also identified in a transcriptomic approach of
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Leuconostoc gasicomitatum, an emerging food spoilage
organism, when grown in meat [58]. The endogeneous
heme present in meat allowed respiration and this
increased growth rate and yield. Interestingly, this had no
impact on the transcriptional response of Leuconostoc
gasicomitatum, similar to what has been observed in Lac-
tococcus lactis [59]. However, it has been described that
the meat-grown Leuconostoc gasicomitatum respiration
activity was increased 1000-fold and was paralleled by
the production of different metabolites, suggesting that
its control is at the metabolic rather than the transcrip-
tional level [58].
Novel insight and functions
While providing a molecular understanding of the adap-
tation of LAB to the food environment, the genomics
studies discussed here also present insight in novel func-
tions. An example is the identification of a novel stress
regulon under the control of the protein Ldb0677 in
Lactobacillus delbrueckii subsp. bulgaricus by using a
proteomic approach and its characterization by molecu-
lar techniques [60]. Moreover, studies in other model
systems may shed new light on the findings in LAB.
One such new insight derives from findings in Bacillus
subtilis, which reportedly shares a common ancestor
with the LAB [19]. It has recently been shown that
CcpA forms complexes with CodY in Bacillus subtilis
and there is no reason to assume this would not be pos-
sible in LAB [61]. This strongly suggests that the carbon
and nitrogen control in LAB are intimately connected.
Similarly, structural analysis of the Bacillus subtilis
CodY indicated that GTP is a ligand for this conserved
regulator and hence CodY reacts to (p)ppGpp levels
formed in the stringent response [62-64]. The stringent
response of the (p)ppGpp alarmone may well be one of
the general triggers that operate in LAB during cheese
fermentation.
The discovery of aerobic respiration in LAB and its
genetic elucidation has been well documented together
with its biotechnological application [59]. This heme-
dependent property has now been found to be operating
in many LAB, including several Lactobacillus, Leuconos-
toc and Enterococcus spp. [57,65,66]. Strictly speaking
respiration is the coupling of a membrane potential to
the reduction of oxygen and this only has been shown
to operate in Lactococcus lactis subsp. cremoris MG1363
when grown on heme [67]. It is of interest to note that
this respiration is so widely spread and appears to occur
in food fermentations when there is a supply of heme-
containing media. Remarkably, also the genome of
Oenococcus oeni contains the genes for aerobic respira-
tion but its functionality has not yet been tested [67].
By an elegant combination of genomics and expression
studies, it has been shown that the Lactococcus lactis
model strains IL1403 contains the genes for pili produc-
tion that can be expressed and are involved in biofilm
production [68]. Prior to this discovery such proteinac-
eous pili had only been described in the GI tract isolate
Lactobacillus rhamnosus GG where they bind human
mucus as well as have a set of other functions, e.g. immu-
nogenicity [69,70]. The presence of these functional pili
genes in strain IL1403 prompted comparative genomics
studies that revealed their presence in various Lactococ-
cus lactis strains, including the other model strain
MG1363, the plant isolate KF147 (see above), and various
other plant and human isolates [68]. The presence of pili
production genes in dairy and plant strains suggests that
this property is multifunctional and provides competitive
advantage in various environments. Interestingly, by
using a combination of proteomics and genomics, a func-
tional pili cluster that enables mucus binding was also
detected in another plant isolate, strain TIL448 [71].
Here, the genes for the pili production are located on a
plasmid, suggesting horizontal gene transfer and proving
a possible mechanism for the apparently wide spread of
this novel function in dairy and plant lactococci.
Functional genomics of LAB in human health
The colonization of LAB in and on the human body has
been well established and 16S rRNA-based phylogenetic
studies have identified LAB at different body sites, such
as the skin, oral cavity, GI tract, and vaginal cavity
[72-77]. Further comprehensive phylogenetic and meta-
genomic characterizations of the human-associated
microbiota using massive parallel sequencing, have
extended this notion and identified the presence, level
and genetic content of the various LAB in the microbial
communities in the human body [4,5]. Based on these
data it can be concluded that the number of total
microbes varies considerably in the various body sites,
as does the fraction of LAB (Figure 3).
The recent genome-based molecular inventories have
shown that the fraction of LAB in the GI-tract is low
and barely reaches over 1 % in only few persons (Figure
3). It is assumed that many of these LAB are passengers
rather than endogenous inhabitants. Still, a detailed phe-
notypic and genomic characterization of strains from
each LAB species is needed to clarify their role within
the GI tract, since some LAB have a high intraspecies
diversity and include both endogeneous and passenger
strains. This has been confirmed in human feeding stu-
dies with marked Lactococcus lactis, showing unex-
pected survival of viable cells [78]. Moreover, a recent
high fat feeding trial where fecal DNA was analysed
using massive parallel sequencing, revealed the transit of
Lactococcus lactis, Streptococcus thermophilus and Ped-
iococcus acidilacti, which are components of dairy and
meat starters [79]. However, based on genomic or
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sequence characteristics various LAB strains have found
to be endogenous in human [56,73,75,80]. By far the
highest fractions of LAB are found in the oral and vagi-
nal cavities since the environment of these relatively
open systems is more accessible than that of the human
GI tract (Figure 3).
While our mouth as the port d’entrée of the GI tract
is receiving a rather variable microbial load of mainly
passengers, the vaginal cavity has a rather stable micro-
biota. This explains why the endogeneous vaginal LAB
were found to be specifically associated with health [81].
This contrasts with the GI tract where most specific
associations with health have been described for other
members of the complex human-associated commu-
nities than LAB [82]. An exception is a recent metagen-
ome study, where Lactobacillus gasseri was associated
with the incidence of type 2 diabetes in a Swedish
cohort [83]. However, this was not reproduced in
another large type 2 diabetes cohort and the observed
genes may have derived from passenger LAB [84].
As many of the genomes of human-derived LAB have
been determined (Figure 2), we summarize the recent
functional genomics studies of these strains below.
The oral cavity
The mouth constitutes the first cavity from which food
is introduced into the digestive tract. As an ecological
habitat, it hosts hundreds of different bacterial species,
including LAB, that are colonizing the teeth, the gum,
the saliva and various locations on the tongue [4].
Teeth, as hard tissues, form an excellent surface for bio-
film formation [85]. A dozen Lactobacilli are found to
be the most prevalent LAB detected in the oral cavity
(Figure 2) [86,87]. Metaproteomic analysis also con-
firmed the presence of Lactobacilli in the human saliva
[88]. Some LAB have been used to restore healthy oral
microbiota and the well-known probiotic Lactobacillus
rhamnosus GG was shown to reduce the population of
Streptococcus mutans, the common cause of caries [89].
Genomic and phenotypic characterization of oral iso-
lates of Lactobacillus rhamnosus indicated that these
were closely related to cheese isolates, suggesting that
they may originate from food products [80]. However,
genomic characterization of Lactobacillus rhamnosus
strains isolated from dental pulp showed that these were
unique and contained an additional set of approximately
250 unique genes [90]. These genes included those
Figure 3 Overview of the level of LAB in the different body sites. The estimated LAB fraction is based on several complete and
comprehensive phylogenetic and metagenomic datasets and the total number of bacteria per gram of homogenized tissue or fluid or square
centimeter of skin [4,94,95,220,221].
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coding for the biosynthesis of exopolysaccharides that
could be involved in biofilm formation, while others
encoded transcriptional regulators and ferric iron ABC
transporters. In the oral isolates of both studies, the
spaCBA-srtC1 pilus gene cluster was lacking, suggesting
that such trait is not essential for persisting in the oral
cavity [80,90].
The gastro-intestinal tract
Isolated or detected throughout the whole digestive tract,
LAB only represent a minor proportion of gastro-intest-
inal microbial communities [73,91]. Typically, represen-
tatives of the Lactobacillus/Enterococcus group constitute
0.01-1.8% of the overall fecal microbiota, as shown by
qPCR techniques [92]. Their abundance in the GI tract
significantly ranges from less than 104 CFU/ml (small
intestine) to 106 CFU/g (faeces) (Figure 3) [73,74,93-95].
The human small intestine was shown to harbour a
diverse population of Streptococci [96]. However,
sequence analysis of the rRNA gene does not allow deter-
mining whether these detected LAB strains are endogen-
ous or transient. Up to date, more than 20 LAB species
have been detected in the digestive tract (Figure 2). Some
of these are consumed as probiotics, such as Lactobacil-
lus plantarum, Lactobacillus casei or Lactobacillus rham-
nosus [8,10,97]. Others are present in the mouth where
they may be derived from food or be endogenous (see
above). This suggests that some of the LAB isolated from
the GI tract may in fact originate from food or the oral
cavity [96,98,99].
Detailed comparative and functional genomic charac-
terization of human LAB isolates may provide answers
whether they are endogenous or transient, as well as
generate a better understanding of their ecological fit-
ness, their adaptation, and their role in their dedicated
niche. The first of these studies related to Lactobacillus
johnsonii and Lactobacillus gasseri, which were genomi-
cally characterized ten years ago (Table 1). Genomic
data complemented with experimental work provide evi-
dence for the ecological adaptation and fitness of Lacto-
bacillus gasseri to the GI tract, as recently reviewed
[100]. Transcriptomic analysis of Lactobacillus johnsonii
NCC533 identified a number of genes that could relate
to its persistence within the intestinal tract [101]. The
isolation and sequencing of intestinal LAB along with
LAB from other sources has allowed us to compare
strains and to determine the diversity of each species
from an ecological but also evolutionary perspective. In
a recent comparative genomic study, the examination of
100 Lactobacillus rhamnosus isolates showed possible
correlations between ecological fitness, phenotypic traits
and genomic modifications [80]. The intraspecies diver-
sity in Lactobacillus rhamnosus was mostly concentrated
in 17 lifestyle islands. Compared to Lactobacillus
rhamnosus food isolates, a subset of GI tract isolates
harbored more prevalently genes associated with specific
carbohydrate pathways (fucose metabolic genes), host
adhesion (mucus-binding SpaCBA pilus gene cluster),
defence and immunity system (CRISPR system) and bio-
film formation (exopolysaccharide cluster). These are
likely to provide an improved capacity to colonize and per-
sist in the GI tract [80]. Intestinal Lactobacillus rhamnosus
isolates were shown to be resistant to bile, whereas isolates
from dairy niches for example were generally less bile-
resistant [80]. Two other closely related species Lactobacil-
lus casei and Lactobacillus paracasei shared some lifestyle
islands with Lactobacillus rhamnosus that were syntenous
[102,103]. Using hybridization arrays and multilocus
sequence typing, the genomic diversity of Lactobacillus
salivarius was studied [104]. In line with findings in other
LAB, the intraspecies diversity was found to be concen-
trated on 18 chromosomal regions that included gene
clusters encoding for the production of exopolysaccharides
[104]. An important fitness factor with applied potential is
the capacity to produce a broad host-range bacteriocin
that allowed Lactobacillus salivarius to outcompete Lis-
teria monocytogenes [105]. In addition to chromosomal
variations, the presence of plasmids and other mobile ele-
ments are playing an important role. One remarkable
example contributing to intraspecies diversity is the pre-
sence of megaplasmids in some Lactobacillus salivarius
strains. Lactobacillus salivarius subsp. salivarius UCC118
harbors the megaplasmid pMP118 (242 kb in size) [106].
Further analysis of two other subspecies identified other
megaplasmids with a different size, suggesting a possible
role in ecological adaptation [106].
Some species such as Lactobacillus reuteri are specia-
lized to one particular host. Lactobacillus reuteri is also
commonly in different human body sites, i.e. breast milk,
GI tract, vagina but it is also found in other vertebrates
[107,108]. Work on the Lactobacillus reuteri species
revealed that strains have distinctly evolved between dif-
ferent hosts. Gut isolates from different mammals, i.e.
rodents and humans have distinct genetic signatures.
This may be explained by the fact that the anatomical
differences between human and rodent gut resulted in
different colonization strategies [109]. The host speciali-
zation observed among Lactobacillus reuteri strains
results from similar genetic mechanisms as in other sym-
biotic bacteria [109]. The role played by transposases in
the genome dynamics between rodent and human iso-
lates differs. The genomes of Lactobacillus reuteri human
gut isolates tends to be smaller with higher number of
pseudogenes [109], as previously reported in other host-
dependent bacteria [110]. In contrast with the Lactobacil-
lus reuteri strains, where it was shown that strain differ
according to the host, comparative genomic analysis
showed that the human gut strain Lactobacillus ruminis
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ATCC 25644 is highly similar to the bovine isolate Lacto-
bacillus ruminis ATCC 27782 [111]. They, however, sig-
nificantly differ from the closely related Lactobacillus
salivarius (Figure 3). Lactobacillus acidophilus and
Lactobacillus helveticus are closely related (Figure 2).
However, Lactobacillus helveticus is typically more spe-
cialized to the dairy environment compared to the gut-
adapted Lactobacillus acidophilus, which has conserved
more biological functions. In the Lactobacillus helveticus
genome, adhesion factors, such as mucus-binding pro-
teins, are absent along with a narrower gene repertoire
encoding for PTS transporters [112,113].
Genome sequences of LAB provided a basis to identify
the secretome and interactome of LAB found in the
human GI tract. Within the Lactobacillus casei group,
the respective LPXTG protein-encoding gene repertoires
of Lactobacillus rhamnosus, Lactobacillus casei and Lac-
tobacillus paracasei shared several similarities [102].
Among others, pilus gene clusters were identified. How-
ever, only in Lactobacillus rhamnosus, the functionality
and expression of one of the gene cluster encoding
mucus-binding pili (spaCBA-srtC1) has been so far
demonstrated [69,114]. This single and outstanding trait
contributes to the highly efficient adhesion of Lactoba-
cillus rhamnosus GG to the intestinal mucosa [69].
Within the Lactobacillus rhamnosus species, pilus-asso-
ciated genes were significantly more present in intestinal
isolates (56 %) compared to dairy isolates (13 %) [80].
Genome-wide analysis of Lactobacillus salivarius
UCC118 identified 108 predicted secreted proteins,
including 10 sortase-anchored proteins. Gene deletion
of sortase and one sortase-anchored protein significantly
reduced the epithelium-binding ability of the strain
UCC118 [115]. A recent review discussed the central
role of sortases and LPXTG proteins for LAB, especially
for the ones found in the GI tract [116]. Interestingly,
some Lactobacillus ruminis strains, i.e. ATCC 27782,
also possess a set of genes encoding for a complete and
functional flagellar apparatus, i.e. 45 flagellar genes, pro-
viding motility [117]. The discovery of motile commen-
sal LAB suggests unique and uncovered impact on the
gut ecology in terms of host signaling and colonization.
In the intestinal Lactobacillus gasseri ATCC 33323,
among the 271 predicted cell surface proteins, at least
14 mucus-binding proteins were identified [118], sug-
gesting a potential role in adherence with the intestinal
mucosa. In Lactobacillus acidophilus L-92, the attach-
ment to epithelial cell lines altered the expression of 78
genes, i.e. membrane proteins, transporters and regula-
tors [119]., Comparative proteomic analysis led to the
identification of 18 proteins with potential adhesive
properties, including surface-layer protein A. Further
work showed that the latter protein has a central role in
the adherence of Lactobacillus acidophilus L-92 to
epithelium [120]. Moreover, one of the well-character-
ized surface-layer proteins, SlpA of Lactobacillus acido-
philus NCFM, was found to bind to the DC-SIGN
receptor of dendritic cells, indicative of a role in intest-
inal signaling [121,122].
A number of similarities in terms of response to the
GI environment have been observed among gut-isolated
LAB species and relate among others to metabolic re-
routing, cell wall modifications or activation of resis-
tance/stress mechanisms. The mechanisms by which
these genes are induced when LAB are in the human
gut are not fully comprehended. Specific attention has
been given to the exposure to bile salts and acids as
during the transit (and eventual colonization) in the GI
tract, LAB are exposed to these environmental stimuli.
Recent proteomic and transcriptomic analysis of the
intestinal Lactobacillus rhamnosus strain GG under bile
stress revealed the activation of numerous genes related
to cell wall functions and possibly operate as a stimulus
for adherence in the intestinal tract [123]. Lactobacillus
rhamnosus strain GG also generated a specific response
towards acid environments, as examined by proteomic
analysis [124]. Similarly, in Lactobacillus casei BL23, 52
proteins showed an altered expression under bile stress,
and these were predicted to be involved in general stress
response, cell wall functions and also carbohydrate
metabolism [125]. Remarkably, in Lactobacillus acido-
philus, glycogen metabolism was found to be associated
with bile resistance [126]. Apart from these laboratory
studies also a series of model animal and human studies
have been reported. An in vivo expression technology
(IVET) study in Lactobacillus plantarum WCFS1 identi-
fied a set of 72 genes that were induced when transiting
the GI tract of mice [127]. These mainly include genes
associated with carbohydrate metabolism, biosynthetic
pathways and transport and also four genes potentially
relating to host interactions, i.e. cell wall anchor pro-
teins [127]. Reciprocally, Lactobacillus plantarum
WCFS1 cells triggered the expression of over 400 genes
in the mucosa of the human small intestine [128,129]. A
mouse study further addressed the transcriptional
responses of Lactobacillus plantarum to different dietary
regimes [130]. Finally, the transcriptional responses to
Lactobacillus plantarum WCFS1 in mice and human
were described in a detailed comparative study that
revealed high level similarities between those systems
[131]. The transcriptomic profile of Lactobacillus plan-
tarum WCFS1 was also found to be modified upon expo-
sure to p-coumaric acid, a component present in
vegetables or fruits, possibly signaling Lactobacillus plan-
tarum to its entry to the digestive tract [132]. Similarly,
the transcriptional response of Lactobacillus plantarum
to bile was also investigated, revealing a set of genes
whose expression is bile-inducible [133]. Within the
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Lactobacillus plantarum species, strains have different
bile sensitivity, i.e. showing either resistance (strain
299V) or sensitivity (strain LC56) [134]. Comparative
proteomic analysis of three different strains led to the
identification of 13 proteins related to bile resistance
mechanisms [134]. In addition, alteration of genes asso-
ciated with cell surface proteins and metabolism suggests
that Lactobacillus plantarum underwent adaptation
when exposed to the murine tract [135]. In intestinal iso-
lates of Lactobacillus reuteri, a total of 28 genes were
shown to be induced under bile salt exposure and pro-
teomic analysis indicated that the encoded proteins were
associated with metabolic pathways, stress-induced
response and also pH homeostasis, which possibly relate
to resistance mechanisms of Lactobacillus reuteri to bile
salt stress [136]. A similar mechanistic response was
observed when exposed to acids [137]. Mice studies
showed that the transcriptome of Lactobacillus johnsonii
NCC533 is changing throughout the GI tract, suggesting
specific responses to each of the GI sites [138]. Using
a mouse model, it was found that 174 Lactobacillus john-
sonii NCC533 genes were expressed in vivo, including
EPS-associated glycosyltransferase genes and PTS trans-
porters [101].
In conclusion, LAB when present in the GI-tract
express a number of common characteristics that relates
their adaptation. These could be summarized as follows:
i. a large repertoire of genes encoding transporters
(ABC, PTS or permeases) to optimally utilize nutrients
available in the gut niche, ii. the presence of genes asso-
ciated with acid and bile resistance, iii. a wide range of
genes promoting interactions and signaling with the
host, such as pili that contain mucus-binding proteins.
The vaginal cavity
LAB members constitute a dominant proportion (~80%)
of bacteria inhabiting the vaginal cavity of healthy women
[139] and are consistently detected in healthy vaginal
microbiota from patients of different ethnic groups and/or
living in different geographical locations [139-143]. Four
main bacterial species were typically identified: Lactobacil-
lus crispatus, Lactobacillus iners, Lactobacillus jensenii
and Lactobacillus gasseri along with, at lesser extent, some
other lactobacilli, such as Lactobacillus acidophilus, Lacto-
bacillus ruminis, Lactobacillus rhamnosus or Lactobacillus
vaginalis [139,144-146]. The high abundance of LAB is
strongly associated with healthy vagina, whereas a low
abundance of LAB, i.e. alteration of the vaginal microbiota,
was more prevalent in women with a medical condition,
i.e. bacterial vaginosis (BV) [140,145,147]. The beneficial
roles of LAB in preserving a healthy vagina include the
maintenance of acidic vaginal pH [148], the prevention of
infections by producing bacteriocins, hydrogen peroxide
and acids, but also by signaling to the host [148-150]. The
understanding of the vaginal microbiota composition not
only contributes to the comprehension of the ecology of
this habitat in health and disease but also offers avenues
towards the development of better diagnostic and thera-
peutic solutions [147,151,152].
Four LAB species are predominantly detected in
human vagina (Lactobacillus crispatus, Lactobacillus
gasseri, Lactobacillus iners and Lactobacillus jensenii)
but co-dominance between LAB species is seldom [142].
This indicates that each vaginal species may harbor
genes that relate to (unique) adaptation signatures and
allow the non-symbiontic persistence and colonization
regardless of the presence of other LAB members [153].
Interestingly, these LAB genomes also showed to be sig-
nificantly smaller and contained a lower GC content
than other LAB genomes, suggesting a loss of non-
essential genes towards a vaginal adaptation [153].
One of the most studied vaginal LAB is the Lactoba-
cillus iners. Remarkably, strains from the Lactobacillus
iners species have a relatively small genome compared
to the LAB, i.e. ~1.3 Mb for Lactobacillus iners AB-1
genome [154] and its intraspecies diversity is peculiarly
low [143]. In line with its genome size, Lactobacillus
iners is not able to biosynthesize many vitamins, cofac-
tors and amino acids, while compensating these meta-
bolic limitations by the presence of numerous genes
encoding transporters [154]. When compared to Lacto-
bacillus crispatus, Lactobacillus gasseri and Lactobacillus
jensenii, Lactobacillus iners carries a variety of unique
genes encoding ABC transporters [153]. The poor meta-
bolic and biosynthetic capabilities illustrate its strong
dependency to the host niche, from where Lactobacillus
iners acquires most of its nutrients. This may also
explain why this species is rarely detected in other eco-
logical niches that are more demanding in terms of
metabolic capabilities [155,156]. Lactobacillus iners is
lacking numerous transcriptional regulators or integral
membrane proteins [153]. The detailed mechanisms
involved the persistence of Lactobacillus iners in the
vagina remain unclear. However, a number of genes
encoding potential adhesins (a total of 11 LPXTG pro-
teins) were identified in Lactobacillus iners AB-1 [154],
along with genes encoding fibronectin-binding type
adhesins [157], indicating that interactions occur
between the bacterial cells and the vaginal tissues. Such
association (lactobacilli-epithelium) promotes exclusion
of pathogens [158], as shown with the displacement of
biofilms formed by Gardnerella vaginalis [159]. In addi-
tion, Lactobacillus iners AB-1 is able to use mucin as a
carbon source, which is clearly beneficial for persisting
in a mucosal niche (vagina) [154]. Interestingly, the gen-
ome of Lactobacillus iners AB-1 contains a gene
(LINAB_0216) that encodes a cytolysin [154]. This gene
is also found in other Lactobacillus iners isolates and its
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product is similar to cholesterol-dependent cytolysins
produced in species such as Streptococcus or Gardner-
ella, [160]. However, its function in L. iners is unclear,
i.e. attachment to host tissues, antimicrobial activity or
pathogenesis [143,160]. A recent meta-RNA-seq based
study showed that during a BV episode Lactobacillus
iners AB-1 modified the expression of genes encoding
the CRISPR-cas system, the cholesterol-dependent cyto-
lysin and the mucin and glycerol transporters [81]. This
underlines adaptive mechanisms towards the persistence
of Lactobacillus iners in changing vaginal microbiota, i.e.
change of nutrient use (mucin and glycogen) and protec-
tion against bacteriophages [81]. The overexpression of
the cholesterol-dependent cytolysin by Lactobacillus iners
during BV appeared to have a detrimental role towards
the host [152]. Based on genomic and transcriptomic data,
Lactobacillus iners was found to be specifically adapted
the vaginal niche under different conditions, i.e. healthy
or non-healthy vaginal microbiota. This remarkable adap-
tation suggests a strong association of Lactobacillus iners
with the host, possibly contributing to maintaining a
healthy microbiota, though its role in BV needs to be
further examined.
In contrast with the Lactobacillus iners species, strains
of all three other vaginal LAB, Lactobacillus crispatus, Lac-
tobacillus gasseri and Lactobacillus jensenii are also found
in other ecological niches than the vagina (Figure 2).
Intestinal Lactobacillus gasseri isolates have genotypic
traits beneficial for persistence and colonization in the gut
(see above) [118]. Comparative genomic analysis identified
a series of species- and/or niche-specific gene sets mostly
consisting of different ABC transporters and regulators
and in some cases toxin-antitoxin systems or cell envelope
proteins [153]. However, no clear vaginal gene sets were
defined in Lactobacillus crispatus, Lactobacillus gasseri
and Lactobacillus jensenii. Vaginal strains of Lactobacillus
crispatus have a larger genome than other strains of this
species, possibly resulting from an abundance of IS-
encoded transposases [153].
Apart from the four dominant LAB species that are
recurrently detected in healthy vaginal microbiota, also
other Lactobacillus spp., can be found and show, in some
cases, unique patterns in both phenotypes and genomes
(Figure 2). In a recent study, vaginal Lactobacillus rham-
nosus isolates were compared with the Lactobacillus
rhamnosus strain GG at both genomic and phenotypic
level [80]. Four main genotypic/phenotypic traits were
highlighted: the lack of mucus-binding pili, their bile
resistance (100% of all isolates), an altered or deficient
CRISPR-cas system compared to strain GG and some
metabolic capabilities similar to food isolates. It was
hypothesized that vaginal LAB may have originated from
food environments or the oral cavity and survived
through the gastro-intestinal tract (bile resistant,
antimicrobial activity), before colonizing the vaginal cav-
ity [80]. The loss of the pilus gene cluster indicates that it
is not beneficial for Lactobacillus rhamnosus in the vagi-
nal cavity. This is consistent with genomic data on other
vaginal LAB, such as Lactobacillus iners, Lactobacillus
gasseri or Lactobacillus crispatus, with genomes that
does not contain such cluster. Recent work on other
LAB, i.e. Lactobacillus plantarum, showed that the vagi-
nal adhesion of the bacterial cells is sortase-dependent
and therefore relies on LPXTG anchor proteins that
likely do not form pili [161]. Similar mechanisms may
occur as well in other LAB, such as Lactobacillus rham-
nosus. No other studies on vaginal Lactobacillus rhamno-
sus genomics have been reported but it seems that only a
subset of the Lactobacillus rhamnosus species may be
able to colonize the vaginal cavity. Most clinical trials
using Lactobacillus rhamnosus strains showed promising
results [162,163]. However, each strain within the species
appear to have a distinct ecological fitness and intestinal
Lactobacillus rhamnosus strain GG with a pheno-geno-
type different from vaginal isolates, was poorly colonizing
the vagina cavity, indicating that it lacks a number of
genes promoting its ecological fitness to the vaginal cav-
ity [164].
Other body sites and clinical cases
In general, LAB are considered to be safe and many spe-
cies are on the list of Qualified Presumed Safety (QPS) of
the European Food Safety Authority [165]. This does not
apply to Enterococcus faecalis and Enterococcus faecium,
two species of enterococci that have been and are used as
starters in various food fermentations as well as marketed
as probiotics (Figure 2) [166]. These enterococci emerged
as the leading causes of antibiotic-resistant infection of
bloodstream, urinary tract and surgical wounds [167].
However, most if not all human are carrying these Enter-
ococcus spp. in their GI tract and it has been suggested
that enterococci may have been ubiquitous colonizers of
the gut since the early Devonian period, i.e. 400 million
years ago [168]. Comparative genomic studies have now
shed light on how such normal colonizing species may
have developed into a major group of pathogens. It
appeared that the genomes of hospital adapted entero-
coccal strains consist of over 25 % of mobile elements,
have lost CRISPR-cas systems that limit horizontal gene
transfer, and have accumulated multiple antibiotic resis-
tance and virulence traits [168]. It has been proposed
that the introduction of antibiotics approximately
75 years ago and their widespread use in both human
and veterinary medicine promoted the rapid evolution of
the present epidemic hospital-adapted lineage not from
human commensals but from a population that included
animal strains [168]. There is some apparent disagree-
ment about the moment of divergence between the
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commensal and hospital lineages of enterococci (300,000
versus 3000 years ago) [168,169]. However, it is tempting
to assume that this occurred after the transition of the
hunter-gatherer, possibly at a time of increasing urbani-
zation of humans, development of hygienic practices, and
domestication of animals as has proposed to contribute
to the ecological separation of these lineages [168]
(Figure 1). Interestingly, a comparative genomic study
indicated that Enterococcus spp. and pathogenic Strepto-
cocci shared more gene families than did the genomes
from non-pathogens, such as other LAB [170].
Inspection of the present QPS listing reveals that
some LAB have incidental cases where they are impli-
cated in non-nosocomial and other clinical infections.
This has been described previously for Lactobacillus
rhamnosus and has been recently reviewed [171]. How-
ever, the increased intake of Lactobacillus rhamnosus
GG did not lead to an increase in bacteremia cases
[172]. Hence, EFSA concluded that clinical infections
especially of Lactobacillus rhamnosus, should be closely
monitored [165]. This also relates to an increasing num-
ber of reports that imply LAB in other body sites than
the canonical caveats (Figure 3). These include strains of
Lactococcus lactis, Leuconostoc lactis, Lactobacillus casei,
Lactobacillus paracasei and Pediococcus sp. [165]. The
number of reports linking Lactococcus lactis, often the
subsp. cremoris, to clinical cases is increasing. Recent
studies include the isolation of Lactococcus lactis from
human brain or neck abcesses or bovine mastitis
[173-175]. It should be remembered that Lactococcus
lactis (then appropriately termed Bacterium lactis) was
the first bacterium grown as a pure culture by Joseph
Lister in 1878. Ironically, Lister compared the fermenta-
tion process with an infection process in his attempts to
illustrate the cause of infectious disease in humans
[176]. It can be expected that further comparative and
functional genomic studies of clinical, food and other
LAB isolates will be instrumental in understanding the
adaptations to the human body as well as assessing the
safety of LAB used in the food or pharmacy industry.
Evolutionary LAB genomics
Adaptation and horizontal gene transfer
It is generally believed that plant material is the archetype
source of the dairy LAB, though some inoculation from
the dairy cow and its milk is also possible (Figure 1).
Recent culture-independent analysis of the foliar micro-
biome, which is rapidly developing and the dairy cow’s
teat showed LAB to be present in both environments
[177,178]. Hence, detailed genomic analysis is needed to
distinguish between the sources of the dairy LAB. Com-
paring the genome of the plant isolate Lactococcus lactis
subsp cremoris KW2 with the dairy strains showed
remarkable similarities apart from the large 21-gene
cluster coding for the biosynthesis of wall techoic acids
that is partially absent or truncated in the model strain
MG1363 or the dairy starters SK11, UC509.9 or A76. In
contrast to the dairy starters, the plant strain KW2 does
not contain any plasmids or IS sequences. This substanti-
ates the earlier suggestions that these mobile elements are
recent acquisitions by horizontal gene transfer. Moreover,
the presence of the gene cluster for the wall techoic acid
production seems to be a plant adaptation as it is also
found in Lactococcus lactis subsp. lactis KF147 isolated
from mung bean sprouts that has been studied extensively
as a non-dairy model for lactococci [23]. This strain
KF147 has one of the largest genomes, shows high identity
and synteny to the genome of Lactococcus lactis subsp.
lactis IL1403 but contains a variety of plant adaptations
that have been lost in the dairy starter of this taxon
[23,179]. Hence, for Lactococci there is ample evidence
that plants are the sources of the dairy strains (Figure 2).
The genome Lactobacillus iners AB-1 is the smallest
among the LAB (Table 1) suggesting that important
gene loss occurred in that species towards the speciali-
zation to one unique ecological habitat, i.e. vaginal cav-
ity. The genome size reduction possibly reflects the
dependency of vaginal LAB to their host, as previously
reported in other symbiotic bacteria, such as Candidatus
Tremblaya princeps (genome size of 139 kb) [180]. The
limited coding capacities of Lactobacillus iners do not
only reflect a remarkable ecological-driven specialization
to the vaginal host but also a strong dependency to this
habitat. The high number of genes associated with DNA
repair, RNA modification and the alteration of a number
of metabolic pathways clearly underline how most of
these vaginal lactobacilli rely on the host for surviving
and persisting. There is a potential mutualistic relation-
ship between the host and the vaginal LAB. The host
provides a stable environment, from where vaginal LAB
can utilize nutrients (mucin, glycogen) or by-products
from other inhabitants. In return, vaginal lactobacilli are
warrant of the maintenance of a healthy vaginal micro-
biota. Although Lactobacillus iners has been reported in
rare clinical cases [155], these may constitute evolution-
ary dead-ends that are usually not associated with any
adaptation traits.
As detailed in the first large scale comparative geno-
mic study, most LAB are phylogenetically closely related
(Figure 2) but mainly differ by the gain of novel genes
or the loss/decay of ancestral genes [19]. In addition,
the number of pseudogenes is highly variable among
LAB, i.e. S. thermophilus CNRZ1066 (182 pseudogenes)
[181] or Pediococcus pentosaceus ATCC 25745 (19 pseu-
dogenes) [19]. The presence of plasmids or megaplas-
mids in some strains are also of interest, since they may
carry additional genes involved in metabolic pathways,
production of bacteriocins and bile salt hydrolase. Two
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striking examples are: the co-existence of 8 plasmids in
Pediococcus claussenii ATCC BAA-344 [182] and the pre-
sence of a 242-kb megaplasmid pMP118 in Lactobacillus
salivarius UCC118 [106]. In addition, horizontal gene
transfer further contribute to genus and species diversifi-
cation, as previously reported in Lactobacillus acidophilus,
Lactobacillus casei, Lactobacillus delbrueckii subsp.
bulgaricus and Lactobacillus johnsonii [103,183-185]. Sig-
nificant differences observed in LAB genomic features give
primary evidence for possible ecological adaptation and
specialization: genome size (coding capacities), pseudo-
genes or plasmids (Table 1). Only a further detailed exam-
ination of these genomes may highlight gained, duplicated,
decayed or lost gene sets that are encoding biological func-
tions relating to one particular ecological context. The role
played by transposases in the genome dynamics between
rodent and human isolates differs. The genomes of Lacto-
bacillus reuteri human gut isolates tends to be smaller
with higher number of pseudogenes [109], as previously
reported in other host-dependent bacteria [110].
Applied LAB genomics
The use of functional and comparative genomics has
greatly enhanced a variety of applications. First, there is
the issue of strain identity and protection. Many manu-
facturers of LAB starters or producers that market LAB
as probiotics, have started to characterize their strains
by complete genomic analysis. While supporting rapid
strain characterization, this is also instrumental in strain
mining and speedily selecting specific properties. More-
over, safety, administrative and legal processes can be
supported by genome sequences and LAB strains of
competitors can be benchmarked. With respect to
safety, one should realize that knowledge of a genome
sequence does not make a strain safe or not. However,
lessons learned from the adaptation of notably Entero-
coccus strains discussed above could be helpful in
further predicting safety of LAB.
The rapid implementation of next generation sequen-
cing technologies for comparative genome analysis has
allowed for several well-known commercial strains to be
made public. It was recently shown that Lactobacillus
casei strains marketed in Yakult and Actimel products
were found to contain only a few dozen single nucleo-
tide polymorphisms (SNPs) and a prophage [186]. This
approach also showed that Lactobacillus rhamnosus GG
isolated from several products was highly stable [114]. A
new genomics approach that is only possible by the
rapid advances in sequencing technology is capitalizing
on genomic resequencing approaches. In a first pub-
lished example Lactococcus lactis NZ9000, containing
the nisRK two-component system genes that are used in
conjunction with the nisin-controlled expression system,
was mutated to increase expression of a variety of
membrane proteins [17,187]. The genomes of the result-
ing 3 strains were compared and found to carry notably
SNPs in the sensor NisK gene [17]. This coupling of
adaptive evolution and high throughput sequencing has
been used in many other studies with LAB, e.g. experi-
mental evolution of Lactobacillus plantarum when
exposed to the murine digestive tract [135]. A recent
report describes an elegant study with the plant isolate
Lactococcus lactis KF147 (see above) that propagated for
1000 generations in milk resulting in faster growth and
biomass yields [188]. Three of the resulting strains were
resequenced and found in two of the cases to have lost
the conjugative transposon needed for growth in plants
(see above). In the rest of the genome only few (6-28)
mutations were detected in various genes, including
those involved in amino acid production and transport.
Remarkably, the strain with most mutations also con-
tained a mutated mutL gene involved in mismatch
repair and believed to increase the mutation frequency
[188]. This example illustrates not only the power of
experimental evolution and the used sequencing tech-
nology but also highlights the domestication process of
a plant strain to the dairy environment.
A final but appealing approach where applied geno-
mics has been used is the in the selection for Lactococ-
cus lactis strains [189]. Cells of the strain MG1363
were mutagenized and serially propagated in water-in-
oil emulsions to allow for selection of strains with
increased biomass yield. One of the resulting strains
coupled an increased biomass to slightly different
growth kinetics and the conversion from homolactic
into a mixed acid fermentation. Genomic resquencing
revealed a SNP mutation in the ptnC gene, encoding a
component of the glucose PTS transport system. The
phenotype of this mutant is explained by decreased
glucose uptake rates, resulting in less acidification and
higher yields without pH control. A series of revertants
were also isolated that upon genomic resequencing
were found to contain an IS905 copy inserted in front
of the ptnABCD operon, resulting in upregulation of
the glucose PTS transport [189]. While these experi-
ments generated further insight in fundamental aspects
of the adaptation processes they also represent the
proof of concept on how to use high throughput
screening and sequencing allowing rapid analysis of the
results. The examples of applied genomics described
here are only a few of the possibilities that can be envi-
saged. Notably, strain optimization in combination with
genomic re-sequencing will be a highly useful tool for
improving starter strains or LAB marketed as probio-
tics. As natural or induced mutations do not lead to
genetically modified organisms, the generated and
improved strains can be used immediately for food or
pharmaceutical applications.
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Concluding remarks
Benefiting from the rapid development of next genera-
tion sequencing techniques, multiple genome sequen-
cing projects on LAB were initiated since the beginning
of the millennium. The data available up to now provide
a comprehensive view on the complexity of the hetero-
geneous LAB group (Figure 2). Detailed comparative
analysis of these genomic data emphasized the remark-
able diversity within the LAB group at numerous taxo-
nomic levels, i.e. order, family, group, genus and even
species. This diversity results from the interactions
between genome and environment as is schematically
depicted (Figure 4). The abundance and variety of nutri-
ents available in a habitat has a direct impact of the
catabolic and biosynthetic properties of LAB. In many
LAB species, the loss of metabolic genes is compensated
by genome enrichment in genes encoding for transpor-
ters (ABC or PTS systems), allowing LAB to use nutri-
ents and by-products from their niche. This
specialization is evident from genome size reduction,
presence of pseudogenes, and genome decay. Still, other
LAB species or strains maintain a broad ecological flex-
ibility, which may cause a high resilience to drastic
environmental changes.
Because LAB are heterotrophs they have developed
intimate interactions with plants and, most likely later,
with animals and humans (Figure 1). Host-associated
LAB contain a large and diverse repertoire of interaction
proteins to adhere and signal to the host. It is tempting
to speculate that the GI tract, as the site where plants
enter the animal body, has played an important role in
this evolutionary process. LAB adapted to the food envir-
onment may not require interaction with any host and
therefore would generally possess a distinct repertoire of
cell surface proteins. Thus, alternative surface proteins
may be involved in the interactions between LAB and
food constituents as compared to the interplay with the
host mucosa [190]. Horizontal gene transfer appears a
major driver of the genomic diversity and plasticity,
affecting genome size and the acquisition of new genes.
Plasmids of different sizes (up to mega-plasmids) and
conjugative transposons have found to be involved in
gene gain and loss.
Surviving in a niche also means to compete with other
microbes and to defend against other inhabitants, includ-
ing bacteriophages. The controlled production of organic
acids and antimicrobials is a highly effective strategy in
this microbiological warfare. Moreover, LAB harbor
Figure 4 Genome, habitat and phenome - a summary overview.
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CRISPR-cas systems to protect from bacteriophages and
other foreign DNA. It seems that the loss of these
defense systems may promote the promiscuous transfer
of various traits, including antibiotic resistance or viru-
lence factors. Finally, tolerance and resistance systems to
endure physico-chemical properties, such as temperature,
acid, salt or bile salts, are essential for LAB living in
foods, the GI tract or other harsh environments.
The area of host-microbe, microbe-microbe and
microbe-molecule interaction is a highly relevant and
timely theme, notably in view of the rapidly expanding
interest in the human GI tract [191]. It may be expected
that the insight worked out for LAB may serve as model
for other microbes. Moreover, as many LAB have
immediate application potential, these systems also may
result in improved or novel strains or processes, as seen
for the discovery of peptide-based quorum sensing in
Lactococcus lactis [192]. Some of the models with
impact at various levels include the CRISPR-cas system
discovered in Streptococcus thermophilus [193], the
communication of Lactobacillus plantarum with the
human host [129], the production of host-interacting
pili in Lactobacillus rhamnosus [69], the evolution of
metabolic strategies in Lactococcus lactis [189] or the
finding of a novel metal-depending lactate racemase in
Lactobacillus plantarum that is widely distributed [194].
The discovery of these models has relied for a large part
on functional genomics, stressing the importance of this
approach in LAB. This provides a promising outlook for
the future where soon all LAB species will be character-
ized at the genomic level, many strains will have been
re-sequenced, and functional and applied genomics are
implemented in academic and industrial environments,
resulting in the further advancement of science and
improvement of the quality of life.
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